These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3166075)

  • 1. Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats.
    Ross DS; Bitzer D; Roy T; Murphy JE
    J Surg Res; 1988 Sep; 45(3):249-53. PubMed ID: 3166075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the chemopreventive agents piroxicam and D,L-alpha-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis.
    Kulkarni N; Zang E; Kelloff G; Reddy BS
    Carcinogenesis; 1992 Jun; 13(6):995-1000. PubMed ID: 1600622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development.
    Rigas B; Tsioulias GJ; Allan C; Wali RK; Brasitus TA
    Immunology; 1994 Oct; 83(2):319-23. PubMed ID: 7835954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
    Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
    Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats.
    Lee D; Dvornik D
    Life Sci; 1985 Mar; 36(12):1157-62. PubMed ID: 3157036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
    Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
    Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
    Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
    Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
    Stoner GD; Qin H; Chen T; Carlton PS; Rose ME; Aziz RM; Dixit R
    Carcinogenesis; 2005 Sep; 26(9):1590-5. PubMed ID: 15878914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.
    Reddy BS; Maruyama H; Kelloff G
    Cancer Res; 1987 Oct; 47(20):5340-6. PubMed ID: 3652039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats.
    Li H; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Cancer Lett; 1999 Dec; 147(1-2):187-93. PubMed ID: 10660105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity.
    Fontán PA; Amura CR; Sordelli DO
    Br J Cancer; 1992 Nov; 66(5):800-4. PubMed ID: 1419623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats.
    Pereira MA; Barnes LH; Steele VE; Kelloff GV; Lubet RA
    Carcinogenesis; 1996 Feb; 17(2):373-6. PubMed ID: 8625466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancer.
    Ross DS; Steele G; Madara J; Lahey SJ; Ravikumar TS; Wilson RE; Munroe AE; Wright D; King VP
    J Natl Cancer Inst; 1984 Sep; 73(3):731-5. PubMed ID: 6590917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroxicam decreases postirradiation colonic neoplasia in the rat.
    Northway MG; Scobey MW; Cassidy KT; Geisinger KR
    Cancer; 1990 Dec; 66(11):2300-5. PubMed ID: 2245384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantable colonic adenocarcinomas in rats.
    Cobb RA; Gartell PC; Steer HW; Suhrbier A; Garrod DR
    Dis Colon Rectum; 1987 Apr; 30(4):255-62. PubMed ID: 3549199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds.
    Reddy BS; Tokumo K; Kulkarni N; Aligia C; Kelloff G
    Carcinogenesis; 1992 Jun; 13(6):1019-23. PubMed ID: 1600605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
    Singh J; Kulkarni N; Kelloff G; Reddy BS
    Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil.
    Nigro ND; Bull AW; Boyd ME
    J Natl Cancer Inst; 1986 Dec; 77(6):1309-13. PubMed ID: 3099048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
    Okajima E; Ozono S; Endo T; Majima T; Tsutsumi M; Fukuda T; Akai H; Denda A; Hirao Y; Okajima E; Nishino H; Nir Z; Konishi Y
    Jpn J Cancer Res; 1997 Jun; 88(6):543-52. PubMed ID: 9263531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.
    Jacoby RF; Marshall DJ; Newton MA; Novakovic K; Tutsch K; Cole CE; Lubet RA; Kelloff GJ; Verma A; Moser AR; Dove WF
    Cancer Res; 1996 Feb; 56(4):710-4. PubMed ID: 8631000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.